The tumor micro-environment (TME) is also seen as a major barrier to CD8+T cell infiltration in breast cancer [10, 16], and it is necessary to overcome this defect for the successful use of immune checkpoint inhibitors [17, 18]. The gene discussed is CD8A; the disease is neoplasm.